Facing highly infectious diseases: new trends and current concepts

Slides:



Advertisements
Similar presentations
Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages
Advertisements

Laboratory diagnosis and biosafety issues of biological warfare agents
C.-S. Lee, J.-H. Lee  Clinical Microbiology and Infection 
Helicobacter pylori resistance to antibiotics in 2014 in France detected by phenotypic and genotypic methods  A. Ducournau, L. Bénéjat, E. Sifré, E. Bessède,
L. Boyanova  Clinical Microbiology and Infection 
Gut bacterial microbiota and obesity
I.J. Schalk  Clinical Microbiology and Infection 
Time-trends for Gram-negative and multidrug-resistant Gram-positive bacteria associated with nosocomial infections in German intensive care units between.
C.-S. Lee, J.-H. Lee  Clinical Microbiology and Infection 
A.K. Reddy, P. Garg, I. Kaur  Clinical Microbiology and Infection 
Candida glabrata fungaemia in intensive care units
J.-P. Van geertruyden  Clinical Microbiology and Infection 
O. Clerc, G. Greub  Clinical Microbiology and Infection 
R. Cantón  Clinical Microbiology and Infection 
Genital Chlamydia trachomatis infections
Louis Pasteur, from crystals of life to vaccination
Human louse-transmitted infectious diseases
Chlamydia trachomatis infections in heterosexuals attending sexually transmitted disease clinics in Slovenia  D. Kese, M. Maticic, M. Potocnik  Clinical.
Increased incidence of nitroimidazole-refractory giardiasis at the Hospital for Tropical Diseases, London: 2008–2013  L.E.B. Nabarro, R.A. Lever, M. Armstrong,
Nosocomial bloodstream infections in children: an 8-year experience at a tertiary-care hospital in Finland  E. Sarvikivi, O. Lyytikäinen, M. Vaara, H.
Clinical Microbiology and Infection
How to evaluate and predict the epidemiologic impact of antibiotic use in humans: the pharmacoepidemiologic approach  D. Guillemot  Clinical Microbiology.
Trends in antibiotic prescribing in general internal medicine wards: antibiotic use and indication for prescription  B. Maraha, M. Bonten, H. Fiolet,
S. Richard, P. Seng, P. Parola, D. Raoult, B. Davoust, P. Brouqui 
Impact of antibiotic restrictions: the pharmaceutical perspective
Vector control: a cornerstone in the malaria elimination campaign
Sofie Arens, Jan Verhaegen, Ludo Verbist 
Training for the infectious diseases speciality in Norway
EuroNHID checklists for the assessment of high-level isolation units and referral centres for highly infectious diseases: results from the pilot phase.
Bacteraemia caused by beta-haemolytic streptococci in North Queensland: changing trends over a 14-year period  P. Harris, D.-A. Siew, M. Proud, P. Buettner,
P. Seng, J.M. Rolain, D. Raoult, P. Brouqui 
Laboratory diagnosis and biosafety issues of biological warfare agents
CMI editorial report 2011 Clinical Microbiology and Infection
B. Y. Lee, Z. S. Wettstein, S. M. McGlone, R. R. Bailey, C. A
Elements of design: the knowledge on which we build
Microbiological and epidemiological studies of Enterococcus faecium resistant to amoxycillin in a university hospital in eastern France  M. Thouverez,
Metagenomics and probiotics
Laboratory diagnosis of Clostridium difficile disease
G.R. Davies  Clinical Microbiology and Infection 
J. Garau  Clinical Microbiology and Infection 
T.M. File  Clinical Microbiology and Infection 
Systematic review of antibiotic consumption in acute care hospitals
F. Blasi, P. Palange, G. Rohde, T. Severin, G. Cornaglia, R. Finch 
Abstracts cont. Clinical Microbiology and Infection
Effect of metronidazole versus standard care on length of stay of patients admitted with severe infectious mononucleosis: a randomized controlled trial 
Twelve years of fluconazole in clinical practice: global trends in species distribution and fluconazole susceptibility of bloodstream isolates of Candida 
A.P. Underwood, J. Green  Clinical Microbiology and Infection 
Antimicrobial drug development – the past, the present, and the future
Circulation of international clones of levofloxacin non-susceptible Streptococcus pneumoniae in Taiwan  Y.-C. Hsieh, L.-Y. Chang, Y.-C. Huang, H.-C. Lin,
Clinical infection services—the Leiden experience
An after-hours clinical liaison blood culture service—is it worth it?
Statin use and clinical outcomes among pneumonia patients
J.-M. Rolain, C. Abat, P. Brouqui, D. Raoult 
O. Clerc, G. Greub  Clinical Microbiology and Infection 
K. Kaier, N.T. Mutters, U. Frank  Clinical Microbiology and Infection 
The atypical pneumonias: clinical diagnosis and importance
J.J. Keller, M.-C. Tsai, C.-C. Lin, Y.-C. Lin, H.-C. Lin 
Virology: a scientific discipline facing new challenges
Serum ferritin levels in West Nile encephalitis
Modelling during an emergency: the 2009 H1N1 influenza pandemic
Are we losing the fight against malaria one more time?
Susceptibility of multi-drug-resistant Pseudomonas aeruginosa in intensive care units: results from the European MYSTIC study group†   H. Goossens  Clinical.
J.L. Balcázar  Clinical Microbiology and Infection 
G.C. Schito  Clinical Microbiology and Infection 
Isolated fever in horses: a new case of equine anaplasmosis in France
J.A. Pérez-Molina, F. Fernández  Clinical Microbiology and Infection 
Impact of antibiotic restrictions: the patient's perspective
L. Bichaud, R. P. Piarroux, A. Izri, L. Ninove, C. Mary, X
CMI readers' survey Clinical Microbiology and Infection
The future of diagnostic bacteriology
Presentation transcript:

Facing highly infectious diseases: new trends and current concepts P. Brouqui  Clinical Microbiology and Infection  Volume 15, Issue 8, Pages 700-705 (August 2009) DOI: 10.1111/j.1469-0691.2009.02873.x Copyright © 2009 European Society of Clinical Infectious Diseases Terms and Conditions

FIG. 1. Example of an airborne isolation room with protective environment (anteroom positive pressure to corridor) as described in reference [35]. Clinical Microbiology and Infection 2009 15, 700-705DOI: (10.1111/j.1469-0691.2009.02873.x) Copyright © 2009 European Society of Clinical Infectious Diseases Terms and Conditions

FIG. 2. Example of a revertible highly infectious disease isolation unit. Blueprint of the Bio Safety Level 3 ward of the infectious disease service of Marseille, France showing the unit when working at bio security level 3. Patients occupying the unit are transferred to the main building. Doors A and B are securely closed. The complete unit is under negative pressure (as indicated) with 25 vol./h air change. Beds in rooms 1 and 2 are removed and rooms 1 and 2 are equipped as dressing/undressing and working anteroom, respectively. Rooms 7 and 8 are equipped for intensive care. The dedicated elevator (E) is used for highly infectious disease patient entrance and exit. All effluents are turned to chlorine disinfection. A negative pressure serving hatch (P) is used to enter healthcare material. Blue Print From AP-HM. Clinical Microbiology and Infection 2009 15, 700-705DOI: (10.1111/j.1469-0691.2009.02873.x) Copyright © 2009 European Society of Clinical Infectious Diseases Terms and Conditions